HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors

Nonspecific distribution of chemotherapeutic drugs (such as paclitaxel) is a major factor contributing to side effects and poor clinical outcomes in the treatment of human head and neck cancer. To develop novel drug delivery systems with enhanced efficacy and minimized adverse effects, we synthesize...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Xu Wang, Jun Li, Yiqing Wang, Kwang Jae Cho, Kim Gloria, Ada Gjyrezi, Lydia Koenig, Paraskevi Giannakakou, Hyung Ju C. Shin, Mourad Tighiouart, Shuming Nie, Zhuo Chen, Dong M. Shin
Format: Artigo
Jezik:angleščina
Izdano: 2009
Online dostop:https://doi.org/10.1021/nn900649v
Oznake: Označite
Brez oznak, prvi označite!